Quantcast

Hawkeye Reporter

Friday, November 22, 2024

FDA conducted third highest number of inspections on Biologics companies in Iowa during Q2 2023

Webp qdyp3hg0n6fiilgeuxkf5yj3s0lo

Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website

Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website

In the second quarter of 2023, four Biologics companies received four FDA inspections in Iowa, according to the U.S. Food and Drug Administration (FDA).

This was the third highest number of inspections per type of company made by the FDA in Iowa, equalling 7% of all inspections in the second quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Iowa During Q2 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products4----
Compliance: Devices11--
Drug Quality Assurance--12
Foodborne Biological Hazards121--
Monitoring of Marketed Animal Drugs, Feed, and Devices3212
Postmarket Assurance: Devices2----
Technical Assistance: Food and Cosmetics2----
Vaccines and Allergenic Products2----

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS